Ibalizumab, active against highly resistant HIV, now approved in US
Biktarvy combo maintains viral suppression after switching therapy
Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys
US regulators approve new HIV combo pill containing bictegravir
Long-acting injectable ARVs are convenient and private, study participants report
New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose
Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time
European Cure Review concentrates on HIV therapeutic vaccines
Symtuza as effective as multi-pill combination in previously untreated people with HIV
